15.04
Nurix Therapeutics Inc Aktie (NRIX) Neueste Nachrichten
Gains Report: Should I buy Nurix Therapeutics Inc stock now2026 Short Interest & Precise Swing Trade Entry Alerts - baoquankhu1.vn
Nurix Stock Is Down 6% This Past Year, but One Biotech Fund Still Boosted Its Bet By $63 Million - AOL.com
Nurix Therapeutics, Inc. (NASDAQ:NRIX) Receives Average Rating of "Moderate Buy" from Analysts - MarketBeat
Surprises Report: Can Oak Woods Acquisition Corporation Equity Right disrupt its industry2026 Snapshot & Pattern Based Trade Signal System - baoquankhu1.vn
A Look At Nurix Therapeutics (NRIX) Valuation After Expanded Equity Distribution Agreement - Sahm
Understanding Momentum Shifts in (NRIX) - Stock Traders Daily
Market Moves: Will Nurix Therapeutics Inc announce a stock splitPortfolio Value Summary & Verified Technical Trade Signals - baoquankhu1.vn
Rhenman & Partners Asset Management AB Purchases 162,500 Shares of Nurix Therapeutics, Inc. $NRIX - MarketBeat
Does Nurix Therapeutics' (NRIX) Expanded ATM Capacity Reframe Its Balance Between Funding Flexibility and Dilution? - Sahm
Can Nurix Therapeutics Inc scale operations efficiently2025 Earnings Impact & Stepwise Trade Signal Guides - baoquankhu1.vn
Is Nurix Therapeutics Inc. stock a top momentum playJuly 2025 Levels & Scalable Portfolio Growth Ideas - Naître et grandir
Nurix Therapeutics amends equity distribution agreement for $413.65 million stock offering - Investing.com
Nurix Therapeutics Expands ATM Equity Offering Capacity - TipRanks
Nurix Therapeutics adds $413.65M at-the-market equity facility with Piper Sandler - TradingView
Inflation Data: Whats the RSI of Nurix Therapeutics Inc stockPortfolio Value Report & Safe Investment Capital Preservation Plans - baoquankhu1.vn
ARK Investment Management LLC Has $13.96 Million Position in Nurix Therapeutics, Inc. $NRIX - MarketBeat
Nurix Therapeutics, Inc. $NRIX Stock Position Increased by Amova Asset Management Americas Inc. - MarketBeat
Handelsbanken Fonder AB Buys 240,000 Shares of Nurix Therapeutics, Inc. $NRIX - MarketBeat
Insider Sell: Christine Ring Sells Shares of Nurix Therapeutics Inc (NRIX) - GuruFocus
Planned stock sale by Nurix (NRIX) chief legal officer disclosed - Stock Titan
Christine Ring sells RSU shares (NRIX) under 10b5-1 plan via Morgan Stanley - Stock Titan
Buybacks Report: What are Calix Incs growth levers2025 Bull vs Bear & AI Based Trade Execution Alerts - baoquankhu1.vn
Nurix Therapeutics (NRIX) Valuation Check After Recent Share Price Volatility And Rich Price To Sales Multiple - Yahoo Finance
NRIX Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan
Avoiding Lag: Real-Time Signals in (NRIX) Movement - Stock Traders Daily
NRIX PE Ratio & Valuation, Is NRIX Overvalued - Intellectia AI
Redmile Group Increases Nurix Therapeutics Stake by 4.4M Shares - Intellectia AI
Nurix Stock Is Down 6% This Past Year, but One Biotech Fund Still Boosted Its Bet By $63 Million - The Motley Fool
Nurix Therapeutics, Inc. (NRIX) Stock Analysis: Is There a 90% Upside Potential on the Horizon? - DirectorsTalk Interviews
Baker Bros discloses 7.2% Nurix (NRIX) ownership stake - Stock Titan
NRIX Technical Analysis & ETF Price Forecast - Intellectia AI
Discipline and Rules-Based Execution in NRIX Response - Stock Traders Daily
Nurix Therapeutics, Inc. (NASDAQ:NRIX) Receives Consensus Rating of "Moderate Buy" from Brokerages - MarketBeat
Nurix Therapeutics Highlights STAT6, BTK and IRAK4 Degraders as Immunology Pipeline Gains Spotlight - MarketBeat
Does Nurix Therapeutics Inc. have a sustainable dividendJuly 2025 Institutional & Entry Point Confirmation Signals - mfd.ru
Is Nurix Therapeutics Inc. undervalued by DCF analysisQuarterly Portfolio Report & Accurate Entry/Exit Alerts - mfd.ru
What is the long term forecast for Nurix Therapeutics Inc. stockEarnings Summary Report & Reliable Trade Execution Plans - mfd.ru
Nurix Therapeutics, Inc. (NRIX) Stock Analysis: Emerging Potential With 90% Upside - DirectorsTalk Interviews
NRIX: Degrader therapies advance in immunology, with key milestones expected for STAT6 and BTK programs - TradingView
Why Nurix Therapeutics Inc. stock remains resilient2025 Earnings Impact & Daily Technical Stock Forecast Reports - mfd.ru
Nurix (NASDAQ: NRIX) CFO awarded 93,750 options and 42,875 RSUs - Stock Titan
Ring Christine, chief legal officer at Nurix, sells $237k in NRIX stock - Investing.com Canada
Assessing Nurix Therapeutics (NRIX) Valuation After Revenue Growth Wider Loss And New Shelf Registration - simplywall.st
HC Wainwright remains a buy on Nurix Therapeutics (NRIX) - MSN
Nurix Therapeutics (NRIX) Is Down 7.4% After Pivotal Bexobrutideg Update and Wider 2025 Loss - Sahm
VIX Spike: Can Nurix Therapeutics Inc sustain its profitabilityGDP Growth & Weekly High Return Stock Forecasts - baoquankhu1.vn
Nurix Therapeutics (NRIX) Is Down 7.4% After Wider 2025 Losses And New ESOP Share ShelfWhat's Changed - Yahoo Finance
Stifel raised Nurix Therapeutics, Inc. (NRIX) price target to $35 and maintains buy ahead of 2026 catalysts - MSN
Nurix Therapeutics advances study for NX-5948 in CLL and SLL patients - MSN
Behavioral Patterns of NRIX and Institutional Flows - Stock Traders Daily
Is Nurix Therapeutics Inc forming a bullish divergenceWeekly Trend Report & Free Risk Controlled Daily Trade Plans - baoquankhu1.vn
Nurix Therapeutics, Inc. (NRIX): A Bull Case Theory - Finviz
Stifel Raised Nurix Therapeutics, Inc. (NRIX) Price Target to $35 and Maintains Buy Ahead of 2026 Catalysts - Finviz
Research Analysts Offer Predictions for NRIX Q1 Earnings - MarketBeat
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):